|
|
Covance Inc. - Comparative Business Analysis Snapshot
Business Description
Covance Inc.. The Group's principal activity is providing a range of product development services, on a worldwide basis. The Group provides services primarily to the pharmaceutical, biotechnology and medical device industries. The Group also provides laboratory-testing services to the chemical, agrochemical and food industries. The operations of the Group are carried out through two segments. The Late-stage Development services segment includes central laboratory, clinical development, commercialization and other clinical support services. The operations of this segment involve evaluating a new compound for safety and early effectiveness as well as evaluating the absorption, distribution, metabolism and excretion of the compound in the human body. The Early Development services segment includes preclinical and Phase I clinical service capabilities.
Competitor Analysis
This analysis compares Covance Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
